Cellebrite DI (CLBT) Projected to Post Earnings on Thursday

Cellebrite DI (NASDAQ:CLBT) will likely be announcing its earnings results before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $107.26 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Cellebrite DI (NASDAQ:CLBT) last posted its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. During the same quarter last year, the firm posted $0.09 EPS. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, analysts expect Cellebrite DI to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cellebrite DI Stock Performance

Shares of CLBT opened at $26.00 on Thursday. The company has a 50 day moving average price of $21.98 and a 200-day moving average price of $18.63. Cellebrite DI has a fifty-two week low of $8.91 and a fifty-two week high of $26.04. The stock has a market capitalization of $5.35 billion, a PE ratio of -16.77, a PEG ratio of 3.55 and a beta of 1.47.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Craig Hallum increased their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Needham & Company LLC raised their price objective on Cellebrite DI from $21.00 to $28.00 and gave the company a “buy” rating in a research report on Wednesday, January 22nd. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a report on Monday, December 16th. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $21.57.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.